Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Morel

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Frontiers in Nephrology|July 3, 2025
Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipientThibault Laban, Fredéric Pigneur, Constance Guillaud, et al.
Ecohealth|November 14, 2009
Improving environmental sanitation, health, and well-being: a conceptual framework for integral interventionsHung Nguyen-Viet, Jakob Zinsstag, Roland Schertenleib, et al.
Kidney International Reports|November 24, 2025
Low Cystatin C-to-Creatinine Estimated GFR Ratio Predicts Post-Kidney Transplant Cardiovascular EventsMichael Moryoussef, Antoine Morel, Louai Zaidan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 2, 2022
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue TherapyAntoine Morel, Léa Hoisnard, Caroline Dudreuilh, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 30, 2025
Myosteatosis as a New Risk Factor of Surgical Complications in Kidney Transplant Recipients: A Retrospective StudyAntoine Morel, Yaniss Ouamri, Lauriane Ségaux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2):  a retrospective cohort studyDominique Bertrand, Marie Matignon, Antoine Morel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximabAntoine Morel, Sandrine Imbeaud, Anne Scemla, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belataceptNathalie Chavarot, Antoine Morel, Marianne Leruez-Ville, et al.
International Journal of Cancer|August 6, 2025
The Fibrosis-4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studiesVictoire de Salins, Claudia Martinez-Tapia, Pierre Gay, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Frontiers in Nephrology|July 3, 2025
Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipientThibault Laban, Fredéric Pigneur, Constance Guillaud, et al.
Ecohealth|November 14, 2009
Improving environmental sanitation, health, and well-being: a conceptual framework for integral interventionsHung Nguyen-Viet, Jakob Zinsstag, Roland Schertenleib, et al.
Kidney International Reports|November 24, 2025
Low Cystatin C-to-Creatinine Estimated GFR Ratio Predicts Post-Kidney Transplant Cardiovascular EventsMichael Moryoussef, Antoine Morel, Louai Zaidan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 2, 2022
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue TherapyAntoine Morel, Léa Hoisnard, Caroline Dudreuilh, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 30, 2025
Myosteatosis as a New Risk Factor of Surgical Complications in Kidney Transplant Recipients: A Retrospective StudyAntoine Morel, Yaniss Ouamri, Lauriane Ségaux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2):  a retrospective cohort studyDominique Bertrand, Marie Matignon, Antoine Morel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximabAntoine Morel, Sandrine Imbeaud, Anne Scemla, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belataceptNathalie Chavarot, Antoine Morel, Marianne Leruez-Ville, et al.
International Journal of Cancer|August 6, 2025
The Fibrosis-4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studiesVictoire de Salins, Claudia Martinez-Tapia, Pierre Gay, et al.
Pageof 4